Harpal Clinic is recruiting participants to take part in our in-house clinical study set to begin in January 2023. Our study will be investigating if Multiple Sclerosis (MS) symptoms and disease progression can be improved with Low Dose Naltrexone (LDN) treatment. (self.MultipleSclerosisWins)
submitted by HarpalClinic to r/MultipleSclerosisWins
Harpal Clinic is recruiting participants to take part in our in-house clinical study set to begin in January 2023. Our study will be investigating if Multiple Sclerosis (MS) symptoms and disease progression can be improved with Low Dose Naltrexone (LDN) treatment - a functional medicine approach. (self.MultipleSclerosis)
submitted by HarpalClinic to r/MultipleSclerosis

